According to the expected core targets of the PPI network that were significantly associated with anti-osteosarcoma effects, the top five target proteins (EGFR, Caspase-3, ESR1, HSP90AA1, and SRC) ranked by degree value were subjected to molecular docking. The gene discussed is CASP3; the disease is osteosarcoma.